HealthcareServices

Nanotechnology In Cancer Treatment Industry Insights: Market Forecast to 2029

November 20, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Nanotechnology In Cancer Treatment Market Size Likely To Evolve From 2025 Through 2034?

The nanotechnology in the cancer treatment market has experienced rapid expansion in recent years. It is anticipated to grow from $137.90 billion in 2024 to $159.09 billion in 2025, achieving a compound annual growth rate (CAGR) of 15.4%. The observed growth during earlier periods can be attributed to the early rise in cancer prevalence worldwide, increased understanding of early cancer detection, greater investments in nanomedicine research and development, a growing preference for minimally invasive treatment options, and expanded government funding for oncology nanotech research.

The nanotechnology in the cancer treatment market size is projected for swift expansion over the coming years, reaching $278.07 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 15.0%. This anticipated growth during the forecast period stems from factors such as increasing demand for targeted cancer therapies, greater integration of nanotechnology into drug delivery systems, an expanding focus on personalized oncology treatment, a rise in clinical trials for nano-enabled cancer drugs, and broader adoption of nanotheranostics in cancer care. Key developments expected during this period involve progress in nanoparticle drug delivery platforms, novel cancer-specific nanocarrier solutions, the incorporation of AI with nanotechnology for precise oncology, the creation of multi-functional nanodevices for both diagnosis and therapy, and the broadening application of nanotheranostics in personalized medicine.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27357&type=smp

Which Industry Drivers Are Expected To Accelerate The Nanotechnology In Cancer Treatment Market From 2025 To 2029?

The increasing need for targeted therapies is projected to drive the expansion of nanotechnology within the cancer treatment market moving forward. These therapies are defined as cancer treatments that specifically target molecular markers or pathways involved in tumor growth and progression. The surge in demand for targeted treatments is attributed to their capability to precisely attack cancer cells, thereby minimizing harm to healthy tissue and reducing side effects. Nanotechnology in cancer treatment further enhances these therapies by enabling precise drug delivery directly to cancer cells, leading to improved effectiveness and reduced damage to healthy tissues. For instance, in July 2023, a report published by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, stated that at the close of Q1 2023, there were 247 gene therapies in Phase II. This number subsequently increased by 5%, reaching 260 by the end of Q2 2023. Thus, the escalating demand for targeted therapies is fueling the growth of nanotechnology in the cancer treatment market.

What Are The Major Segments Identified In The Nanotechnology In Cancer Treatment Market?

The nanotechnology in cancer treatment market covered in this report is segmented

1) By Nanotechnology Type: Liposomes, Dendrimers, Nanoparticles

2) By Treatment Type: Chemotherapy, Immunotherapy, Targeted Therapy, Combined Therapy Approaches, Surgery Assistance

3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, Other Cancer Types

4) By Application: Targeted Drug Delivery, Photothermal Therapy, Radiation Therapy Enhancement, Diagnostics And Imaging, Gene Delivery Systems

5) By End-User: Hospitals, Research Institutions, Diagnostics Laboratories, Pharmaceutical Companies, Contract Research Organizations (CROs)

Subsegments:

1) By Liposomes: Conventional Liposomes, Stealth Liposomes, Cationic Liposomes, Immunoliposomes

2) By Dendrimers: Polyamidoamine Dendrimers, Polypropyleneimine Dendrimers, Peptide-Based Dendrimers, Carbosilane Dendrimers

3) By Nanoparticles: Gold Nanoparticles, Magnetic Nanoparticles, Polymeric Nanoparticles, Quantum Dots, Lipid Nanoparticles

What Key Innovation Trends Are Fueling Advancements In The Nanotechnology In Cancer Treatment Market?

Leading companies in the nanotechnology in cancer treatment market are prioritizing the development of advanced therapies, such as immunotherapy nano formulation, to enhance immune system targeting and mitigate adverse effects for cancer patients. Immunotherapy nano formulation employs nanotechnology to deliver immune-based treatments directly to specific target sites, thereby improving treatment precision while simultaneously boosting drug stability, bioavailability, and the activation of immune responses. For instance, in December 2023, Cello Therapeutics, a US-based biotechnology company, launched CE120, a broad-spectrum therapeutic cancer nano vaccine that successfully obtained Food and Drug Administration clearance. This therapy signifies the initial clinical use of platelet membrane-coated nanoparticles for the treatment of solid tumors. CE120 combines targeted drug delivery with the stimulation of the immune system, aiming to eliminate tumors and prevent their recurrence. Its distinct nanotechnology platform enhances both the accuracy of the therapy and the efficacy of the immune response. This significant accomplishment positions CE120 as a groundbreaking nanomedicine in cancer treatment.

Which Major Industry Participants Are Leading The Nanotechnology In Cancer Treatment Market Growth?

Major companies operating in the nanotechnology in cancer treatment market are Pfizer Inc., AstraZeneca PLC, Novartis AG, Amgen Inc., GE Healthcare Technologies Inc., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Arrowhead Pharmaceuticals Inc., Nanobiotix S.A., EnGeneIC Ltd., Nanospectra Biosciences Inc., Sona Nanotech Inc., CritiTech Inc., Immix Biopharma Inc., DNA Nanobots LLC, Nanovery Limited, CytImmune Sciences Inc., NanOlogy LLC, NanoApps Medical Inc., ARIZ Precision Medicine.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/nanotechnology-in-cancer-treatment-global-market-report

How Do Regional Market Performances Compare Within The Nanotechnology In Cancer Treatment Industry?

North America was the largest region in the nanotechnology in cancer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanotechnology in cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Nanotechnology In Cancer Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27357&type=smp

Browse Through More Reports Similar to the Global Nanotechnology In Cancer Treatment Market 2025, By The Business Research Company

Biosurfactants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biosurfactants-global-market-report

Core Materials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/core-materials-global-market-report

Biomaterials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biomaterials-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795